ACT-660602: an Oral Chemokine Receptor CXCR3 Antagonist for Autoimmune Diseases

ACT-660602

oral CXCR3 antagonist efficacy in mice model of lung inflammation from HTS and opt J. Med. Chem. Idorsia Pharmaceuticals Ltd., Allschwil, CH

Drug Hunter Team